ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,776.65
0.16%
US Tech 100
19,738.40
0.00%
Dow Jones
42,587.50
0.01%
Brent Oil
72.605
-0.01%
Bitcoin
88,102.54
0.73%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Nuvectis Pharma Inc (NVCT) Quote

Nuvectis Pharma Inc

Nuvectis Pharma Inc (NVCT)

NASDAQ
8.68
0.00
(0.00%)
Closed March 26 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
8.68
Bid
8.37
Ask
9.90
Volume
-
0.00 Day's Range 0.00
4.44 52 Week Range 11.80
Market Cap
203.038M
Previous Close
8.68
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
117,534
Shares Outstanding
23,391,499
Dividend Yield
-
PE Ratio
-10.69
Earnings Per Share (EPS)
-0.81
Revenue
-
Net Profit
-19M

About Nuvectis Pharma Inc

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.nuvectis.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $8.68. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 4.44 to $ 11.80.

Nuvectis Pharma currently has 23,391,499 shares outstanding. The market capitalization of Nuvectis Pharma is $203.04 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -10.69.

Ask ADVFN Intelligence (AI)

NVCT Latest News

More News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
February 25 2025
NVCT (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
February 25 2025
NVCT (0.00%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
February 06 2025
NVCT (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
February 05 2025
NVCT (0.00%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
February 04 2025
NVCT (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 03 2025
NVCT (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 03 2025
NVCT (0.00%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
January 03 2025
NVCT (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 20 2024
NVCT (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.72-7.659574468099.410.678.681747039.59882797CS
41.5521.73913043487.1310.675.871141708.49001598CS
123.2359.26605504595.4510.675.321175347.33972386CS
262.4338.886.2511.84.441462486.93472154CS
52-0.26-2.908277404928.9411.84.441144966.85481695CS
1561.6222.94617563747.0620.924.44716578.88322124CS
2604.73119.7468354433.9520.923.081834027.81164391CS

NVCT - Frequently Asked Questions (FAQ)

What is the current Nuvectis Pharma share price?
The current share price of Nuvectis Pharma is $ 8.68
How many Nuvectis Pharma shares are in issue?
Nuvectis Pharma has 23,391,499 shares in issue
What is the market cap of Nuvectis Pharma?
The market capitalisation of Nuvectis Pharma is USD 203.04M
What is the 1 year trading range for Nuvectis Pharma share price?
Nuvectis Pharma has traded in the range of $ 4.44 to $ 11.80 during the past year
What is the PE ratio of Nuvectis Pharma?
The price to earnings ratio of Nuvectis Pharma is -10.69
What is the reporting currency for Nuvectis Pharma?
Nuvectis Pharma reports financial results in USD
What is the latest annual profit for Nuvectis Pharma?
The latest annual profit of Nuvectis Pharma is USD -19M
What is the registered address of Nuvectis Pharma?
The registered address for Nuvectis Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Nuvectis Pharma website address?
The website address for Nuvectis Pharma is www.nuvectis.com
Which industry sector does Nuvectis Pharma operate in?
Nuvectis Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 77.53
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACGATA Creativity Global
$ 1.01
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.04
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 77.53
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACGATA Creativity Global
$ 1.01
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.04
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 77.53
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACGATA Creativity Global
$ 1.01
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.04
(0.00%)
0

NVCT Discussion

View Posts
gail gail 4 months ago
grabbed some on the dip
👍️0
Monksdream Monksdream 7 months ago
NVCT under $10
👍️0
Monksdream Monksdream 9 months ago
NVCT under $10
👍️0
Monksdream Monksdream 11 months ago
NVCT under $10
👍️0
Monksdream Monksdream 1 year ago
NVCT 10Q due March 6
👍️0
Monksdream Monksdream 1 year ago
NVCT a bounce
👍️0
conix conix 3 years ago
NVCT HIGHLIGHTS:

*Recently completed Initial Public Offering - $5.00 Per share
*2 Precision Cancer medicines in development - ovarian and triple negative breast
*Data flow throughout 2022
*CEO with multiple success stories in life science sector to $billion dollar market caps
*Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

Nuvectis Pharma Inc - Company Background:

Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

Market Capitalization: $225 million
Range - 52 week: $3.08 - $20.75
Current Price: $20.44
Trades on: Nasdaq Capital Market
Ticker Symbol: NVCT

website: nuvectis.com
👍️0
TheFinalCD TheFinalCD 3 years ago
wow from $3 to almost $21
👍️0
ipo_dude ipo_dude 3 years ago
$27 we come
👍️0
TheFinalCD TheFinalCD 3 years ago
WOW $7 MOVE 3-10


CONGRAT$ NVCT
👍️0
spindog spindog 3 years ago
I feel the same
👍️0
kkballa kkballa 3 years ago
hmmm.
👍️0

Your Recent History

NASDAQ
NVCT
Nuvectis Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads